Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

BACKGROUND: To measure circulating anti-citrullinated peptide antibodies (ACPA) and cytokines pre- and 6 months post-therapy as a strategy to predict and optimize responses to traditional disease-modifying antirheumatic drugs (DMARDs) in early RA, which is an unmet need in developing countries. PATI...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Musculoskelet Disord
Autores principales: Ally, Mahmood M. T. M., Hodkinson, Bridget, Meyer, Pieter W. A., Musenge, Eustasius, Tintinger, Gregory R., Tikly, Mohammed, Anderson, Ronald
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4446850/
https://ncbi.nlm.nih.gov/pubmed/26021985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-015-0587-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares